|
Re: PCSK9 Inhibitors Improve Patient Outcomes, But Will That Convince Payers to Pay for Them?
|
3
|
Resverlogix Corp.
|
Apr 10, 2017 11:40AM
|
|
biOasis Closes Oversubscribed Non-Brokered Private Placement
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 11, 2017 11:02PM
|
|
Re: breaking news...Apple forms secret team to address Diabetes?
|
3
|
Resverlogix Corp.
|
Apr 13, 2017 10:23AM
|
|
Re: breaking news...Apple forms secret team to address Diabetes?
|
4
|
Resverlogix Corp.
|
Apr 13, 2017 10:55AM
|
|
Re: EAS Poster Sessions Apabetalone is there
|
2
|
Resverlogix Corp.
|
Apr 15, 2017 10:10AM
|
|
Re: New Frontiers for both RVX/Zenith
|
2
|
Resverlogix Corp.
|
Apr 18, 2017 10:16AM
|
|
Re: Month 10
|
3
|
Zenith Epigenetics
|
Apr 18, 2017 12:08PM
|
|
Everyone just take a deep breath
|
6
|
Resverlogix Corp.
|
Apr 20, 2017 10:15AM
|
|
Re: Short interest creeps up again.....
|
4
|
Resverlogix Corp.
|
Apr 20, 2017 01:13PM
|
|
Re: Short interest creeps up again.....
|
3
|
Resverlogix Corp.
|
Apr 20, 2017 01:24PM
|
|
Re: Short interest creeps up again.....
|
4
|
Resverlogix Corp.
|
Apr 20, 2017 02:44PM
|
|
Re: Extended Betonmace trial
|
3
|
Resverlogix Corp.
|
Apr 20, 2017 05:28PM
|
|
Re: Exempt Distribution on SEDAR
|
2
|
Resverlogix Corp.
|
Apr 21, 2017 04:21PM
|
|
Re: Exempt Distribution on SEDAR
|
|
Resverlogix Corp.
|
Apr 21, 2017 04:45PM
|
|
Re: Not acting like a company worried about the PPS.....
|
|
Resverlogix Corp.
|
Apr 24, 2017 03:45PM
|
|
Re: New CEO
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 24, 2017 09:07PM
|
|
BIOASIS APPOINTS MARK DAY, PH.D., AS CHIEF EXECUTIVE OFFICER AND DIRECTOR
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 24, 2017 09:08PM
|
|
BIOASIS ANNOUNCES INVESTOR RELATIONS SERVICE AGREEMENT
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 24, 2017 09:10PM
|
|
BIOASIS ANNOUNCES GRANT OF STOCK OPTIONS AND RESTRICTED STOCK UNITS
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 24, 2017 09:17PM
|
|
Re: New CEO
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 24, 2017 09:26PM
|
